OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1310$8.0458

Taiwan Styrene Monomer Corp

Commodity ChemicalsVerified

Capital Structure and Liquidity The company's liquidity position is constrained, with a current ratio of 0.89 and negative free cash flow of -469.75 million TWD. The price-to-book ratio of 0.57 and tangible book ratio of 0.57 indicate a market valuation below the book value of equity. The debt-to-equity ratio of 0.2 suggests a relatively conservative capital structure, but the negative operating cash flow of -102.11 million TWD raises concerns about short-term liquidity. ### Profitability and Returns Profitability is severely challenged, with a net loss of 724.62 million TWD and a return on equity of -9.79%. The return on assets of -7.27% and a negative EBITDA multiple of -7.81 indicate poor asset utilization and operational performance. Gross profit of -542.29 million TWD and operating income of -722.33 million TWD further underscore the company's financial distress. ### Segments and Geographic Exposure The company operates through five segments, with the plastics segment being the primary contributor to its chemical product line. The engineering and electronics segments provide ancillary services and sales, while the investment and other segments include non-core activities such as hotel operations and medical equipment wholesale. Revenue is heavily concentrated in the domestic Taiwan market, with no significant international exposure disclosed. ### Growth Trajectory The company's growth trajectory is uncertain, with a net loss in the latest reporting period and no clear indication of improvement in the near term. The capital expenditure of -15.59 million TWD suggests minimal investment in expansion or modernization. The outlook for the current and next fiscal years remains negative, with no material revenue growth expected. ### Risk Factors The company faces medium liquidity risk due to negative free cash flow and a current ratio below 1. The risk assessment flags a negative net cash position after subtracting total debt. While dilution risk is currently low, the company's financial performance and capital structure could change if it requires additional financing. The ESG governance score of 69.6 and social score of 63.8 suggest moderate ESG performance, but the controversies score of 100.0 indicates potential reputational risks. ### Recent Events Recent filings and transcripts do not indicate any material events or strategic shifts. The company's financial performance remains a key focus, with no significant operational or strategic developments reported in the latest disclosures.

30-day price · 1310-3.00 (-27.5%)
Low$7.90High$11.55Close$7.90As of15 May, 00:00 UTC
Profile
CompanyTaiwan Styrene Monomer Corp
Ticker1310.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Taiwan Styrene Monomer Corporation produces and sells styrene monomer and related chemical products, primarily serving the domestic market in Taiwan, with operations spanning plastics, engineering, electronics, investment, and other segments.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

### Capital Structure and Liquidity The company's liquidity position is constrained, with a current ratio of 0.89 and negative free cash flow of -469.75 million TWD. The price-to-book ratio of 0.57 and tangible book ratio of 0.57 indicate a market valuation below the book value of equity. The debt-to-equity ratio of 0.2 suggests a relatively conservative capital structure, but the negative operating cash flow of -102.11 million TWD raises concerns about short-term liquidity. ### Profitability and Returns Profitability is severely challenged, with a net loss of 724.62 million TWD and a return on equity of -9.79%. The return on assets of -7.27% and a negative EBITDA multiple of -7.81 indicate poor asset utilization and operational performance. Gross profit of -542.29 million TWD and operating income of -722.33 million TWD further underscore the company's financial distress. ### Segments and Geographic Exposure The company operates through five segments, with the plastics segment being the primary contributor to its chemical product line. The engineering and electronics segments provide ancillary services and sales, while the investment and other segments include non-core activities such as hotel operations and medical equipment wholesale. Revenue is heavily concentrated in the domestic Taiwan market, with no significant international exposure disclosed. ### Growth Trajectory The company's growth trajectory is uncertain, with a net loss in the latest reporting period and no clear indication of improvement in the near term. The capital expenditure of -15.59 million TWD suggests minimal investment in expansion or modernization. The outlook for the current and next fiscal years remains negative, with no material revenue growth expected. ### Risk Factors The company faces medium liquidity risk due to negative free cash flow and a current ratio below 1. The risk assessment flags a negative net cash position after subtracting total debt. While dilution risk is currently low, the company's financial performance and capital structure could change if it requires additional financing. The ESG governance score of 69.6 and social score of 63.8 suggest moderate ESG performance, but the controversies score of 100.0 indicates potential reputational risks. ### Recent Events Recent filings and transcripts do not indicate any material events or strategic shifts. The company's financial performance remains a key focus, with no significant operational or strategic developments reported in the latest disclosures.
Key takeaways
  • The company is operating at a net loss with negative free cash flow and poor profitability metrics.
  • Liquidity is constrained, with a current ratio below 1 and negative operating cash flow.
  • Revenue is heavily concentrated in the domestic Taiwan market, with no significant international exposure.
  • The capital structure is relatively conservative, but the negative EBITDA and ROE suggest poor operational performance.
  • ESG controversies score is high, indicating potential reputational risks despite moderate governance and social scores.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$8.67B
Gross profit-$542.3M
Operating income-$722.3M
Net income-$724.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$102.1M
CapEx-$15.6M
Free cash flow-$469.7M
Total assets$9.96B
Total liabilities$2.56B
Total equity$7.40B
Cash & equivalents$117.9M
Long-term debt$1.51B
Valuation
Market price$8.04
Market cap$4.24B
Enterprise value$5.64B
P/E
Reported non-GAAP P/E
EV/Revenue0.7
EV/Op income
EV/OCF
P/B0.6
P/Tangible book0.6
Tangible book$7.40B
Net cash-$1.39B
Current ratio0.9
Debt/Equity0.2
ROA-7.3%
ROE-9.8%
Cash conversion14.0%
CapEx/Revenue-0.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1310Activity
Op margin-8.3%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-8.4%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin-6.3%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity20.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar69.6
market data ESG social pillar63.8
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 01:04 UTC#24ecdc8b
Market quoteclose TWD 8.04 · shares 0.53B diluted
no public URL
2026-05-15 01:06 UTC#25262aa1
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 01:08 UTCJob: 3f858f16